These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29754812)

  • 1. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.
    Abraham WT; Kuck KH; Goldsmith RL; Lindenfeld J; Reddy VY; Carson PE; Mann DL; Saville B; Parise H; Chan R; Wiegn P; Hastings JL; Kaplan AJ; Edelmann F; Luthje L; Kahwash R; Tomassoni GF; Gutterman DD; Stagg A; Burkhoff D; Hasenfuß G
    JACC Heart Fail; 2018 Oct; 6(10):874-883. PubMed ID: 29754812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.
    Wiegn P; Chan R; Jost C; Saville BR; Parise H; Prutchi D; Carson PE; Stagg A; Goldsmith RL; Burkhoff D
    Circ Heart Fail; 2020 Apr; 13(4):e006512. PubMed ID: 32264716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration.
    Neelagaru SB; Sanchez JE; Lau SK; Greenberg SM; Raval NY; Worley S; Kalman J; Merliss AD; Krueger S; Wood M; Wish M; Burkhoff D; Nademanee K
    Heart Rhythm; 2006 Oct; 3(10):1140-7. PubMed ID: 17018340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design.
    Abraham WT; Lindenfeld J; Reddy VY; Hasenfuss G; Kuck KH; Boscardin J; Gibbons R; Burkhoff D;
    J Card Fail; 2015 Jan; 21(1):16-23. PubMed ID: 25285748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
    Abraham WT; Nademanee K; Volosin K; Krueger S; Neelagaru S; Raval N; Obel O; Weiner S; Wish M; Carson P; Ellenbogen K; Bourge R; Parides M; Chiacchierini RP; Goldsmith R; Goldstein S; Mika Y; Burkhoff D; Kadish A;
    J Card Fail; 2011 Sep; 17(9):710-7. PubMed ID: 21872139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    Eur J Heart Fail; 2024 Apr; 26(4):1051-1061. PubMed ID: 38606555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of cardiac contractility modulation in heart failure treatment.
    Chinyere IR; Balakrishnan M; Hutchinson MD
    Curr Opin Cardiol; 2022 Jan; 37(1):30-35. PubMed ID: 34698667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM; Lawo T; Butter C; Schmidinger H; Lunati M; Pieske B; Misier AR; Curnis A; Böcker D; Remppis A; Kautzner J; Stühlinger M; Leclerq C; Táborsky M; Frigerio M; Parides M; Burkhoff D; Hindricks G
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
    Mann JA; Abraham WT
    Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive individual patient data meta-analysis of the effects of cardiac contractility modulation on functional capacity and heart failure-related quality of life.
    Giallauria F; Cuomo G; Parlato A; Raval NY; Kuschyk J; Stewart Coats AJ
    ESC Heart Fail; 2020 Oct; 7(5):2922-2932. PubMed ID: 32700809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.
    Yu CM; Chan JY; Zhang Q; Yip GW; Lam YY; Chan A; Burkhoff D; Lee PW; Fung JW
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1341-9. PubMed ID: 20083066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
    Giallauria F; Vigorito C; Piepoli MF; Stewart Coats AJ
    Int J Cardiol; 2014 Aug; 175(2):352-7. PubMed ID: 24975782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac contractility modulation in heart failure with reduced ejection fraction patients with QRS duration 120-149 ms: Reduction in heart failure hospitalizations and improvement in functional outcome.
    Fastner C; Varma N; Rao I; Falk P; Remppis BA; Najarian K; Burkhoff D; Akin I; Kuschyk J
    Heart Rhythm; 2024 Sep; ():. PubMed ID: 39306264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.
    Atchley AE; Kitzman DW; Whellan DJ; Iskandrian AE; Ellis SJ; Pagnanelli RA; Kao A; Abdul-Nour K; O'Connor CM; Ewald G; Kraus WE; Borges-Neto S;
    Am Heart J; 2009 Oct; 158(4 Suppl):S53-63. PubMed ID: 19782789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.